Antibiotics Penicillin entered mass production in 1944 and revolutionized the treatment of several venereal diseases. Antibiotics are used to treat<unk>  infections. As of 2016, both ceftriaxone by injection and azithromycin by mouth are most effective. However, due to increasing rates of antibiotic resistance, local susceptibility patterns must be taken into account when deciding on treatment. Adults may have eyes infected with<unk>  and require proper personal hygiene and medications. Addition of topical antibiotics have not been shown to improve cure rates compared to oral antibiotics alone in treatment of eye infected<unk> . For newborns, erythromycin ointment is recommended as a preventative measure for gonococcal infant conjunctivitis. Infections of the throat can be especially problematic, as antibiotics have difficulty becoming sufficiently concentrated there to destroy the bacteria. This is amplified by the fact that pharyngeal<unk>  is mostly asymptomatic, and gonococci and commensal Neisseria species can coexist for long time periods in the pharynx and share anti-microbial resistance genes. Accordingly, an enhanced focus on early detection (i.e., screening of high-risk populations, such as men who have sex with men, PCR testing should be considered) and appropriate treatment of pharyngeal<unk>  is important. Sexual partners It is recommended that sexual partners be tested and potentially treated. One option for treating sexual partners of people infected is patient-delivered partner therapy (PDPT), which involves providing prescriptions or medications to the person to take to his/her partner without the health care provider's first examining him/her. The United States' Centers for Disease Control and Prevention (CDC) currently recommend that individuals who have been diagnosed and treated for<unk>  avoid sexual contact with others until at least one week past the final day of treatment in order to prevent the spread of the bacterium. Antibiotic resistance Many antibiotics that were once effective including penicillin, tetracycline, and fluoroquinolones are no longer recommended because of high rates of resistance. Resistance to cefixime has reached a level such that it is no longer recommended as a first-line agent in the United States, and if it is used a person should be tested again after a week to determine whether the infection still persists. Public health officials are concerned that an emerging pattern of resistance may predict a global epidemic. The UK's Health Protection Agency reported that 2011 saw a slight drop in<unk>  antibiotic resistance, the first in five years. In 2016, the WHO published new guidelines for treatment, stating "There is an urgent need to update treatment recommendations for gonococcal infections to respond to changing antimicrobial resistance (AMR) patterns of N.<unk> e. High-level resistance to previously recommended quinolones is widespread and decreased susceptibility to the extended-spectrum (third-generation) cephalosporins, another recommended first-line treatment in the 2003 guidelines, is increasing and several countries have reported treatment failures."
Gonorrhea
Vaginal yeast infection
Logorrhea 
Leukorrhea
Creatorrhea
Blennorrhea
Rhinorrhea
Cryptomenorrhea